Format

Send to

Choose Destination
Helicobacter. 2016 Sep;21 Suppl 1:26-9. doi: 10.1111/hel.12336.

Inflammation, immunity, and vaccines for Helicobacter pylori infection.

Author information

1
Service of Gastroenterology and Hepatology, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.
2
ImevaX GmbH, Munich, Germany.
3
Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany.

Abstract

The tight control of the innate and adaptive immune responses in the stomach mucosa during chronic Helicobacter pylori infection is of prime importance for the bacteria to persist and for the host to prevent inflammation-driven diseases. This review summarizes recent data on the roles of innate and adaptive immune responses during H. pylori/host interactions. In addition, the latest preclinical developments of H. pylori vaccines are discussed with a special focus on the clinical trial reported by Zeng et al., who provided evidence that oral vaccination significantly reduces the acquisition of natural H. pylori infection in children.

KEYWORDS:

H. pylori; innate and adaptive immunity; vaccine development

PMID:
27531535
DOI:
10.1111/hel.12336
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center